PCMH
ALNY icon

Polymer Capital Management (HK)’s Alnylam Pharmaceuticals ALNY Stock Holding History

Polymer Capital Management (HK)’s Portfolio ALNY Stock Details ALNY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$19.6M Buy
64,957
+7,173
+12% +$2.16M 0.99% 12
2026
Q1 		$19.1M Buy
57,784
+21,019
+57% +$7.15M 1.65% 9
2025
Q4 		$14.6M Buy
36,765
+7,865
+27% +$3.48M 2.08% 13
2025
Q3 		$13.2M Buy
28,900
+31
+0.1% +$12.6K 1.82% 13
2025
Q2 		$9.41M Buy
28,869
+11,065
+62% +$3.06M 1.42% 24
2025
Q1 		$4.81M Buy
17,804
+7,491
+73% +$1.93M 0.82% 37
2024
Q4 		$2.43M Buy
+10,313
New +$2.71M 0.42% 67

Other funds holding ALNY

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Polymer Capital Management (HK)'s ALNY Position: Q2 2026 in Review

Polymer Capital Management (HK) increased its Alnylam Pharmaceuticals (ALNY) stake by 12% in Q2 2026, buying an estimated $2.16M and bringing the position to 64,957 shares worth $19.6M. The position accounts for 0.99% of the portfolio, ranked #12.

Polymer Capital Management (HK) first reported a position in ALNY in Q4 2024 and has held it in 7 quarters since. 788 funds tracked by Wall St. Rank hold ALNY as of Q2 2026.

  • Polymer Capital Management (HK) held 64,957 shares of Alnylam Pharmaceuticals worth $19.6M as of Q2 2026.
  • Polymer Capital Management (HK) bought 7,173 Alnylam Pharmaceuticals shares in Q2 2026, an estimated $2.16M.
  • Alnylam Pharmaceuticals made up 0.99% of Polymer Capital Management (HK)'s portfolio in Q2 2026, its #12 holding.
  • Polymer Capital Management (HK) first reported a position in Alnylam Pharmaceuticals in Q4 2024 and has held it in 7 quarters since.
  • 788 funds tracked by Wall St. Rank held Alnylam Pharmaceuticals as of Q2 2026.

Based on Polymer Capital Management (HK)'s 13F filing for Q2 2026, filed 13 Aug 2026.